Cagri / GLP-1
Cagri / GLP-1, 5mg / 5mg. A long-acting amylin analog with a GLP-1 receptor agonist. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. Cagri and GLP-1 are combined in a single 10 mg vial, 5 mg of each. Cagri is a long-acting amylin-analog research compound; GLP-1 is a GLP-1 receptor agonist research compound. The pairing is one of the most studied combinations in the metabolic literature, though the two are characterised separately rather than as a single formulation.
Amylin analogs are characterised at the calcitonin and amylin receptor complexes. Satiety signalling and gastric-emptying rate are the measured endpoints.
GLP-1 receptor agonism is characterised for glucose-dependent insulin release, with gastric emptying and food-intake endpoints also measured.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | Cagri / GLP-1 |
| Category | Peptide Blends |
| Lot Number | MBP-2713 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!